Snapshot from Aug 06, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Kalshi expands to drug trial betting
Regulatory product launch

Kalshi expands to drug trial betting

Analysis based on 10 articles · First reported Jul 16, 2026 · Last updated Jul 16, 2026

Sentiment
10
Attention
3
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The expansion could increase trading volume and interest in Kalshi's platform, potentially attracting new users from the biotech sector. However, regulatory scrutiny and concerns about insider trading may limit growth.

prediction markets biotechnology pharmaceuticals
Event Summary

Kalshi Inc., a prediction market platform, announced an expansion into biotechnology by offering wagers on clinical trial outcomes and FDA regulatory decisions. The move, in partnership with AI firm AppliedXL, includes 13 new biotech contracts on drugs from companies like Sanofi and Gilead Sciences. Kalshi also filed documentation with the CFTC to offer flight cancellation rate contracts using FlightAware data. The company released a white paper on prediction markets in drug development, featuring input from 23andMe co-founder Anne Wojcicki and former Eli Lilly scientist Alpheus Bingham. Kalshi plans to implement safeguards such as employment verification and listing contracts only after trial enrollment closes to prevent insider trading. Critics raise concerns about market manipulation and addiction, while Kalshi emphasizes compliance and transparency.

Key Actions
90 Kalshi launched biotech contracts
50 Kalshi filed documentation United States — United States Commodity Futures Trading Commission
40 Kalshi released white paper
30 Kalshi donated to problem gambling National Council on Problem Gambling
Entities Involved
exch
Kalshi
Kalshi is the central entity launching new prediction markets for drug trials and flight delays, aiming to increase its user base and trading volume.
Importance 100.0 Sentiment 60.0
govactor
United States — United States Commodity Futures Trading Commission
The CFTC regulates prediction markets and received Kalshi's filing for flight delay contracts; its chair Michael S. Selig has supported drug-trial contracts.
Importance 50.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
The FDA's regulatory decisions are the subject of some of Kalshi's new contracts.
Importance 40.0 Sentiment 0.0
priv
AppliedXL
AppliedXL partnered with Kalshi to provide AI intelligence for the biotech contracts.
Importance 40.0 Sentiment 30.0
stock
Sanofi
Sanofi is one of the companies whose drug approvals are being bet on, but is not directly involved.
Importance 20.0 Sentiment 10.0
per
Michael S. Selig
Michael S. Selig, CFTC chair, has touted drug-trial contracts as a way for patients to hedge treatment costs.
Importance 20.0 Sentiment 10.0
stock
Gilead Sciences
Gilead Sciences is one of the companies whose drug approvals are being bet on, but is not directly involved.
Importance 20.0 Sentiment 10.0
per
Anne Wojcicki
Anne Wojcicki, co-founder of 23andMe, consulted on Kalshi's biotech initiative and expressed support for transparent trial data.
Importance 20.0 Sentiment 15.0
priv
FlightAware
FlightAware provides flight tracking data for Kalshi's proposed flight cancellation contracts.
Importance 20.0 Sentiment 10.0
per
Tarek Mansour
Tarek Mansour, Kalshi's CEO, announced the expansion and emphasized compliance and transparency.
Importance 20.0 Sentiment 15.0
per
Alpheus Bingham
Alpheus Bingham, former Eli Lilly scientist, consulted on Kalshi's biotech initiative and founded InnoCentive.
Importance 15.0 Sentiment 10.0
stock
23andMe
23andMe's co-founder Anne Wojcicki provided input as an unpaid consultant for Kalshi's initiative.
Importance 15.0 Sentiment 10.0
priv
Polymarket
Polymarket is a rival prediction market platform mentioned as having offered healthcare contracts in the past.
Importance 10.0 Sentiment -10.0
stock
Eli Lilly and Company
Eli Lilly is mentioned as the former employer of Alpheus Bingham, who helped build an internal prediction market.
Importance 10.0 Sentiment 5.0
govactor
United States — United States Department of Transportation
The DOT is mentioned as a backup data source for flight cancellation contracts.
Importance 10.0 Sentiment 0.0
+ 4 more entities View on Dashboard
Relationships
Kalshi regulated exchange ↔ United States — United States Commodity Futures Trading Commission Kalshi is a federally regulated Designated Contract Market (DCM) under the direct oversight of the U.S. Commodity Future
Kalshi related ↔ Michael S. Selig
United States — United States Commodity Futures Trading Commission related ↔ Michael S. Selig
United States — Food and Drug Administration related ↔ Sanofi
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.